Summary
The global Neglected Tropical Diseases Drugs And Vaccine Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Neglected Tropical Diseases Drugs And Vaccine Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Neglected Tropical Diseases Drugs And Vaccine Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Artecef BV
- GlaxoSmithKline
- AstraZeneca
- Novartis
- Sanofi-Aventis
- Ranbaxy Labs
- Lupin
- Macleods Pharmaceuticals
- Cipla
- Romark Laboratories
- Toyama Chemica
By the Product Type, the market is primarily segmented into:
- Malaria
- Ebola
- Dengue
- Chagas
- Leishmaniasis
- Other
- Market segment by Application, split into
- Drugs
- Vaccines
By Applications, the market is segmented into:
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Neglected Tropical Diseases Drugs And Vaccine Market Report:
- To assess the size of the market by value and volume
- Analyze the Neglected Tropical Diseases Drugs And Vaccine Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Neglected Tropical Diseases Drugs And Vaccine Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Neglected Tropical Diseases Drugs And Vaccine Market
The Neglected Tropical Diseases Drugs And Vaccine Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Neglected Tropical Diseases Drugs And Vaccine Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Malaria
1.4.3 Ebola
1.4.4 Dengue
1.4.5 Chagas
1.4.6 Leishmaniasis
1.4.7 Other
1.5 Market by Application
1.5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2020 VS 2026
1.5.2 Drugs
1.5.3 Vaccines
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2015-2026)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Regions
2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Share by Regions (2015-2020)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Neglected Tropical Diseases Drugs and Vaccine Market Growth Strategy
2.3.6 Primary Interviews with Key Neglected Tropical Diseases Drugs and Vaccine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Market Size
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2015-2020)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2015-2020)
3.1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2019
3.3 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.4 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.5 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2015-2020)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2021-2026)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application (2015-2026)
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
6.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in North America (2019-2020)
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
7.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Europe (2019-2020)
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
8 China
8.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
8.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in China (2019-2020)
8.3 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
8.4 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
9.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Japan (2019-2020)
9.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
9.4 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
10.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
11 India
11.1 India Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
11.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in India (2019-2020)
11.3 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
11.4 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
12.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Central & South America (2019-2020)
12.3 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
12.4 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Artecef BV
13.1.1 Artecef BV Company Details
13.1.2 Artecef BV Business Overview and Its Total Revenue
13.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
13.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020))
13.1.5 Artecef BV Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
13.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview and Its Total Revenue
13.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
13.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
13.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Sanofi-Aventis
13.5.1 Sanofi-Aventis Company Details
13.5.2 Sanofi-Aventis Business Overview and Its Total Revenue
13.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
13.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.5.5 Sanofi-Aventis Recent Development
13.6 Ranbaxy Labs
13.6.1 Ranbaxy Labs Company Details
13.6.2 Ranbaxy Labs Business Overview and Its Total Revenue
13.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
13.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.6.5 Ranbaxy Labs Recent Development
13.7 Lupin
13.7.1 Lupin Company Details
13.7.2 Lupin Business Overview and Its Total Revenue
13.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
13.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.7.5 Lupin Recent Development
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Details
13.8.2 Macleods Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
13.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.8.5 Macleods Pharmaceuticals Recent Development
13.9 Cipla
13.9.1 Cipla Company Details
13.9.2 Cipla Business Overview and Its Total Revenue
13.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
13.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.9.5 Cipla Recent Development
13.10 Romark Laboratories
13.10.1 Romark Laboratories Company Details
13.10.2 Romark Laboratories Business Overview and Its Total Revenue
13.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
13.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
13.10.5 Romark Laboratories Recent Development
13.11 Toyama Chemica
10.11.1 Toyama Chemica Company Details
10.11.2 Toyama Chemica Business Overview and Its Total Revenue
10.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
10.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
10.11.5 Toyama Chemica Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Neglected Tropical Diseases Drugs and Vaccine Key Market Segments
Table 2. Key Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
Table 3. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Malaria
Table 6. Key Players of Ebola
Table 7. Key Players of Dengue
Table 8. Key Players of Chagas
Table 9. Key Players of Leishmaniasis
Table 10. Key Players of Other
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2015-2020)
Table 15. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Neglected Tropical Diseases Drugs and Vaccine Market Growth Strategy
Table 21. Main Points Interviewed from Key Neglected Tropical Diseases Drugs and Vaccine Players
Table 22. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2015-2020) (Million US$)
Table 23. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2015-2020)
Table 24. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2019)
Table 25. Global Neglected Tropical Diseases Drugs and Vaccine by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 28. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Type (2015-2020)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2021-2026)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Application (2015-2020)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Application (2021-2026)
Table 36. North America Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 40. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 41. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 42. Europe Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 44. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 48. China Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 49. China Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 50. China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 51. China Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 52. China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 53. China Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 54. Japan Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 56. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 58. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 62. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 64. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 66. India Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 67. India Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 68. India Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 69. India Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 70. India Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 71. India Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Neglected Tropical Diseases Drugs and Vaccine Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Neglected Tropical Diseases Drugs and Vaccine Market Share (2019-2020)
Table 74. Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2015-2020)
Table 76. Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2015-2020)
Table 78. Artecef BV Company Details
Table 79. Artecef BV Business Overview
Table 80. Artecef BV Product
Table 81. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 82. Artecef BV Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Product
Table 86. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 87. GlaxoSmithKline Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Product
Table 91. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 92. AstraZeneca Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Product
Table 96. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 97. Novartis Recent Development
Table 98. Sanofi-Aventis Company Details
Table 99. Sanofi-Aventis Business Overview
Table 100. Sanofi-Aventis Product
Table 101. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 102. Sanofi-Aventis Recent Development
Table 103. Ranbaxy Labs Company Details
Table 104. Ranbaxy Labs Business Overview
Table 105. Ranbaxy Labs Product
Table 106. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 107. Ranbaxy Labs Recent Development
Table 108. Lupin Company Details
Table 109. Lupin Business Overview
Table 110. Lupin Product
Table 111. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 112. Lupin Recent Development
Table 113. Macleods Pharmaceuticals Business Overview
Table 114. Macleods Pharmaceuticals Product
Table 115. Macleods Pharmaceuticals Company Details
Table 116. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 117. Macleods Pharmaceuticals Recent Development
Table 118. Cipla Company Details
Table 119. Cipla Business Overview
Table 120. Cipla Product
Table 121. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 122. Cipla Recent Development
Table 123. Romark Laboratories Company Details
Table 124. Romark Laboratories Business Overview
Table 125. Romark Laboratories Product
Table 126. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 127. Romark Laboratories Recent Development
Table 128. Toyama Chemica Company Details
Table 129. Toyama Chemica Business Overview
Table 130. Toyama Chemica Product
Table 131. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020) (Million US$)
Table 132. Toyama Chemica Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2020 VS 2026
Figure 2. Malaria Features
Figure 3. Ebola Features
Figure 4. Dengue Features
Figure 5. Chagas Features
Figure 6. Leishmaniasis Features
Figure 7. Other Features
Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2020 VS 2026
Figure 9. Drugs Case Studies
Figure 10. Vaccines Case Studies
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions: 2020 VS 2026
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2019
Figure 17. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2019
Figure 19. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Artecef BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 30. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 34. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 36. Ranbaxy Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 38. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 40. Macleods Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 42. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 44. Romark Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 46. Toyama Chemica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Request Discount 
Inquire Before Buy
